Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

844
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
844
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

128
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
128
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

101
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
101
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

192
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
192
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

160
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
160
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

115
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Perilous Journey of Patients With Primary CNS-HLH to Bone Marrow Transplant: A Case Report.

Case reports in hematology·2026
Same author

The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient.

Clinical pharmacology and therapeutics·2026
Same author

Translation readiness of model-based synthetic tabular data in healthcare: a systematic review and governance audit.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.

medRxiv : the preprint server for health sciences·2026
Same author

Expanding the Toolbox: Utility of HistioTrak for Minimal Residual Monitoring in Pediatric Patients with Langerhans Cell Histiocytosis Treated with Targeted Therapy.

Cancers·2026
Same author

Interpretable multiple instance learning for hematologic diagnosis from peripheral blood smears.

Communications medicine·2026

Related Experiment Video

Updated: Aug 3, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Synthetic Model Combination: A new machine-learning method for pharmacometric model ensembling.

Alexander Chan1, Richard Peck2,3,4, Megan Gibbs5

  • 1Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.

CPT: Pharmacometrics & Systems Pharmacology
|April 12, 2023
PubMed
Summary

Synthetic Model Combination (SMC) addresses challenges in pharmacological predictions when data sharing is limited. This instance-wise ensembling method weights models based on data domain relevance, improving prediction accuracy.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

428
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K

Related Experiment Videos

Last Updated: Aug 3, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

428
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K

Area of Science:

  • Pharmacology
  • Machine Learning
  • Data Science

Background:

  • Data-driven pharmacological predictions rely on labeled examples, but data sharing limitations often result in multiple models trained on disparate populations.
  • Existing methods for combining models (global selection or ensembling) create a single model, which performs poorly on out-of-domain data due to covariate shift.

Purpose of the Study:

  • To introduce a novel instance-wise ensembling method, Synthetic Model Combination (SMC), for improved pharmacological predictions.
  • To address the challenge of combining multiple models trained on disparate datasets when data sharing is not feasible.

Main Methods:

  • Developed Synthetic Model Combination (SMC), an instance-wise ensembling technique.
  • Incorporated a representation learning step within SMC to manage sparse, high-dimensional data.
  • Applied SMC to vancomycin dosing predictions as a case study.

Main Results:

  • SMC demonstrated effective model ensembling by weighting individual instances based on their domain relevance.
  • The method showed improved prediction performance in the vancomycin dosing example.
  • The approach is adaptable to various scenarios requiring the combination of multiple predictive models.

Conclusions:

  • Synthetic Model Combination (SMC) offers a robust solution for ensembling machine learning models in pharmacological settings with limited data sharing.
  • The instance-wise weighting mechanism effectively mitigates issues arising from covariate shift.
  • SMC is a versatile method applicable to diverse prediction tasks involving multiple, independently trained models.